Find us on:

LDNscience® is a public information project of the MedInsight® Research Institute, which is a U.S./U.K. based non-profit organization established in 2006. MedInsight® serves as a platform for researching and indexing available off-label (repurposed) treatments for cancer and chronic diseases.

Our People

Our Founder

Moshe Rogosnitzky
Research Scientist, Innovator and Inventor

Our Team Members

We thank the generous sponsors who keep LDNscience® going.

Visit our CureLeaders® Board where you can see our generous supporters.

Bronze

Wendy Lowe

Diamond

Nicole Solomon

Big LDN fan - Good luck!!

Gold

Louise Andreas

LDN has saved my life! Thank you!

Bronze

Peter Bauman

Proud to support LDNscience! Keep up the good work!

Revamped LDN site launched -- biggest patient-initiated drug discovery program in history
MedInsight® Announces Clinical Trial Results of Low-dose Naltrexone; Potential Breakthrough For Crohn's Disease Patients
LDNscience® Media Release - New Website Aims to Clear Up Misconceptions About Breakthrough Drug Low Dose Naltrexone (LDN)